Skip to content

The Pre-Assay Checklist: RUO Materials, COSHH and the Purchaser’s Laboratory Duties

What RUO Supply Means Before an In-Vitro Assay Is Booked

A new in-vitro assay booking is a commitment of time, bench space, staff and documentation. Before the calendar slot is confirmed, the materials manager and researcher should separate supply questions from experimental questions. Research-use-only (RUO) supply sits at the centre. Research Sciences supplies high-purity research peptides, laboratory accessories and preparation tools for controlled in-vitro scientific research. Products are strictly for laboratory and analytical research; they are not medicines, medical devices, injectables, treatments or food supplements under UK law, and they are not for human or veterinary use. The FAQs describe products as labelled “For Research Use Only – Not for Human Consumption”, in line with MHRA guidance as the shop’s stated position, not legal advice. The supplier also states that it does not provide therapeutic, medical, performance, injection, ingestion or dosing guidance, and that orders inconsistent with its compliance standards may be refused. RUO is not a casual label; it defines the intended use boundary.

The purchaser’s first check is suitability. Does the assay require a defined peptide, a solvent, a storage container or a preparation tool? Is the material’s documented form, purity and handling compatible with the in-vitro workflow? Research Sciences publishes CoAs for products; FAQs state every compound includes an HPLC CoA for purity and identity, manufactured by international partners using solid-phase peptide synthesis and independently tested by HPLC, with final UK verification and quality checks before release. The homepage lists “CoAs Janoshik Analytical Reports”, “≥99% Verified Purity”, “3,000+ UK Orders”, “24hr UK Delivery” and “7 Days Expert Customer Support” as current published wording; these claims should be reconfirmed on the live site and against the specific batch CoA. Do not treat a headline purity figure as a substitute for the batch document. Exact purity is stated on the CoA.

Excipients and format matter. FAQs state all peptides contain trace amounts of mannitol, used as an excipient. A researcher should ask whether that excipient interferes with the assay before booking. The shop does not supply blended peptides; it recommends buying peptides individually and combining only within a controlled experimental design. A practical starting point for catalogue and documentation review is the published research materials listed by Peptides uk, but the controlling record is the CoA accompanying the batch. If the material is not clearly suitable for the intended in-vitro application, the assay should not be booked.

COSHH and the Purchaser’s Pre-Order Laboratory Assessment

COSHH is a purchaser’s responsibility, not a box ticked by the supplier. Even when a material is RUO and handled only in vitro, the laboratory must consider whether it is hazardous to health under the local COSHH assessment. The buyer is responsible for lawful use, safe handling, storage, disposal and compliance with relevant UK regulations including COSHH and laboratory safety standards, and for checking suitability for the intended research application. Before a purchase order or assay booking, the lab should identify who will handle the material, where it will be stored, what personal protective equipment and engineering controls are needed, how spills will be managed, and how waste will be segregated and disposed of. Training records should be in place. The assessment should be written into the local system before the first vial arrives, not after the assay date is fixed.

Storage and handling requirements feed directly into COSHH. Published handling guidance is that vials should be allowed to reach room temperature before opening; work should take place in a clean environment; only the amount required for the experiment should be removed. Lyophilised peptides should be stored at –20°C or below, sealed with desiccant and protected from moisture, heat and light; repeated freeze–thaw cycles should be avoided. Reconstituted peptides are less stable and should be stored at 2–8°C for short-term laboratory use. The MT-1 product page gives an example for that specific listing: lyophilised powder, storage at −20°C protected from moisture and light, and 2–8°C after reconstitution, with reconstitution solutions supplied separately. Those details should not be copied onto other products; check each listing and CoA.

Reconstitution must stay inside an in-vitro laboratory workflow: diluent volume and concentration for the assay, not administration. The free reconstitution calculator is described for laboratory research use only and must not be used for human or veterinary dosing. If the assay plan depends on a solvent, check that the solvent is supplied or sourced appropriately and that the final in-vitro concentration is compatible with the detection method. This is also the point to confirm that no one is planning to use the material for therapeutic, clinical, diagnostic, ingestion or injection purposes; the materials are not for human or veterinary use. If the COSHH assessment, storage capacity, waste route or training is not ready, booking the assay creates avoidable compliance risk.

Documentation, Batch Records and Scheduling Before the Assay Calendar Is Fixed

Documentation should be reconciled before the assay date is booked. Open the CoA that accompanies the specific batch, not only the product page. Check identity, purity and the tests described for that batch. The homepage lists Janoshik Analytical Reports; the researcher should open and check the actual CoA. The About page describes full-spectrum testing as purity, identity, heavy metals and endotoxin evaluation of submitted samples, with CoAs linked to supported products. The FAQs state that every product includes a CoA for purity and identity. Where a published figure such as ≥99% purity or 3,000+ UK orders is cited, treat it as the shop’s current published wording and reconfirm it on the live site; for purity, the batch CoA controls.

Batch traceability has limits. FAQs say restocked products may carry the same Internal Test Reference (ITR) as earlier stock. An ITR links to associated sample testing reports; it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Vial cap colours and other packaging may vary; cap colour is not an indicator of identity, analytical quality or manufacturing origin. Vial labels use a reference format combining SKU code and expiry date, for example BPC10-03/27, linking to the corresponding CoA. Quote that reference when contacting the shop about documentation. Materials managers should attach the relevant CoA and label reference to the internal purchase record so the assay file is auditable.

Scheduling must include fulfilment and returns policy. Published terms state that all orders are dispatched the next working day and shipped via Royal Mail Tracked 24, which usually delivers the following working day as a Royal Mail estimate; tracking is provided after dispatch, and delivery times may vary in peak periods. The homepage “24hr UK Delivery” line is marketing wording and should not be treated as a guaranteed next-day arrival; reconfirm at checkout. No returns are accepted once dispatched because of the specialist and perishable nature of the goods; refunds are only for damage, incorrect supply or quality issues, as in the Refunds & Returns Policy. Build that into the assay calendar. Do not book the assay until the CoA, COSHH assessment, storage location, handling training, waste route and delivery estimate have been checked and recorded. The materials remain research-use-only and are not for human or veterinary use.